Philip J. Rubinfeld serves as Executive at WOUND MANAGEMENT TECHNOLOGIES, INC., where they oversee executive responsibilities. Since joining the company, Philip J. Rubinfeld has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 27, 2017 involved receiving (via award) 150,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 27, 2017 | WNDM | $0 | Award | 150,000 | $N/A | Discretionary |
Philip J. Rubinfeld currently holds 500,000 shares of WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip J. Rubinfeld has been a net neutral trader of WNDM stock. They have purchased $0 and sold $0 worth of shares.
Philip J. Rubinfeld's most recent insider trade was on Feb 27, 2017, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted